Literature DB >> 19231593

Biology of the eosinophil.

Carine Blanchard1, Marc E Rothenberg.   

Abstract

In this review, we aim to put in perspective the biology of a multifunctional leukocyte, the eosinophil, by placing it in the context of innate and adaptive immune responses. Eosinophils have a unique contribution in initiating inflammatory and adaptive responses, due to their bidirectional interactions with dendritic cells and T cells, as well as their large panel of secreted cytokines and soluble mediators. The mechanisms and consequences of eosinophil responses in experimental inflammatory models and human diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231593      PMCID: PMC4109275          DOI: 10.1016/S0065-2776(08)01003-1

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  205 in total

1.  A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation.

Authors:  S P Hogan; A Mishra; E B Brandt; M P Royalty; S M Pope; N Zimmermann; P S Foster; M E Rothenberg
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  Eotaxin and eosinophil recruitment: implications for human disease.

Authors:  S M Rankin; D M Conroy; T J Williams
Journal:  Mol Med Today       Date:  2000-01

3.  Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses.

Authors:  Hiroko Saito Akei; Eric B Brandt; Anil Mishra; Richard T Strait; Fred D Finkelman; Manoj R Warrier; Gurjit K Khurana Hershey; Carine Blanchard; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2006-06-09       Impact factor: 10.793

4.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

5.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Treatment of patients with the hypereosinophilic syndrome with mepolizumab.

Authors:  Marc E Rothenberg; Amy D Klion; Florence E Roufosse; Jean Emmanuel Kahn; Peter F Weller; Hans-Uwe Simon; Lawrence B Schwartz; Lanny J Rosenwasser; Johannes Ring; Elaine F Griffin; Ann E Haig; Paul I H Frewer; Jacqueline M Parkin; Gerald J Gleich
Journal:  N Engl J Med       Date:  2008-03-16       Impact factor: 91.245

Review 7.  Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation.

Authors:  Adrian M Piliponsky; Gerald J Gleich; Ilan Bar; Francesca Levi-Schaffer
Journal:  Mol Immunol       Date:  2002-09       Impact factor: 4.407

Review 8.  Steroid resistance in asthma.

Authors:  P J Barnes; I M Adcock
Journal:  QJM       Date:  1995-07

9.  Essential and instructive roles of GATA factors in eosinophil development.

Authors:  Ryutaro Hirasawa; Ritsuko Shimizu; Satoru Takahashi; Mitsujiro Osawa; Shu Takayanagi; Yuko Kato; Masafumi Onodera; Naoko Minegishi; Masayuki Yamamoto; Katashi Fukao; Hideki Taniguchi; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

Review 10.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

View more
  92 in total

Review 1.  Practical approach to the patient with hypereosinophilia.

Authors:  Florence Roufosse; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2010-06-09       Impact factor: 10.793

Review 2.  Eosinophil crystalloid granules: structure, function, and beyond.

Authors:  Valdirene S Muniz; Peter F Weller; Josiane S Neves
Journal:  J Leukoc Biol       Date:  2012-06-06       Impact factor: 4.962

Review 3.  The Eosinophil in Infection.

Authors:  Karen A Ravin; Michael Loy
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 4.  IgE, mast cells, basophils, and eosinophils.

Authors:  Kelly D Stone; Calman Prussin; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

5.  Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Authors:  Alana B Levine; George Kalliolias; Mark Heaney; Yoshimi Endo; Adam Gersten; Jonathan W Weinsaft; Robert F Spiera; Anne Bass; Doruk Erkan
Journal:  HSS J       Date:  2012-06-23

6.  Proteomic and Phosphoproteomic Changes Induced by Prolonged Activation of Human Eosinophils with IL-3.

Authors:  Stephane Esnault; Alexander S Hebert; Nizar N Jarjour; Joshua J Coon; Deane F Mosher
Journal:  J Proteome Res       Date:  2018-05-04       Impact factor: 4.466

Review 7.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

8.  Safety and efficiency of active immunization with detoxified antigen against scorpion venom: side effect evaluation.

Authors:  Nassrine Bachsais; Lila Boussag-Abib; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2017-05-17       Impact factor: 4.575

Review 9.  Activation of Human Eosinophils with Nanoparticles: a New Area of Research.

Authors:  Marion Vanharen; Denis Girard
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

10.  Eosinophil survival and apoptosis in health and disease.

Authors:  Yong Mean Park; Bruce S Bochner
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.